Isehara, Japan

Tatsuo Ito


Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1983-1985

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Tatsuo Ito

Introduction

Tatsuo Ito is a notable inventor based in Isehara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral and antibiotic agents. With a total of four patents to his name, his work has the potential to impact the treatment of various viral diseases.

Latest Patents

One of his latest patents is focused on antiviral agents. This patent discloses an antiviral agent that comprises as an active component a substance known as SF-2140, along with a pharmaceutically acceptable carrier. The patent also outlines a method for treating viral diseases by administering a pharmaceutically effective amount of the substance SF-2140. Another significant patent involves an antibiotic SF-2103A substance and the process for its production. This patent describes the antibiotic SF-2103A substance or a salt thereof, along with a process that includes cultivating an antibiotic SF-2103A substance-producing strain in a nutrient medium and recovering the desired substance from the culture broth.

Career Highlights

Tatsuo Ito is currently associated with Meiji Seika Kaisha, Ltd., a company known for its advancements in the pharmaceutical industry. His work at this company has allowed him to focus on innovative solutions that address pressing health concerns.

Collaborations

Throughout his career, Tatsuo has collaborated with notable colleagues such as Takashi Shomura and Tomizo Niwa. These collaborations have likely contributed to the success of his inventions and patents.

Conclusion

Tatsuo Ito's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in the treatment of viral and bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…